Atul Gawande, MD, has penned an article in the Annals of Surgery calling for his fellow surgeons to do their part in reducing the supply of excess prescription painkillers by embracing new technologies that would allow them to prescribe opioids electronically.
Atul Gawande, MD, has penned an article in the Annals of Surgery calling for his fellow surgeons to do their part in reducing the supply of excess prescription painkillers by embracing new technologies that would allow them to prescribe opioids electronically.
While at first this proposition may appear contradictory, Gawande argued that surgeons currently tend to overprescribe opioid pain relievers, knowing that refills without a written prescription are difficult to obtain and could leave patients stranded in pain if the supply runs out. If clinicians could send prescriptions digitally, however, they could write initial prescriptions for a smaller quantity of pills while confident they would be able to remotely order more if needed.
Additionally, Gawande explained that electronic prescribing, or e-prescribing, would help prevent duplicate prescriptions, reduce dosing errors, integrate with prescription drug monitoring databases, and improve patients’ experiences after surgery.
He relayed the story of one of his patients who was accidently discharged without a prescription for pain medication, so that by the time he returned home “he was miserable with pain.” A family member had to drive back to the hospital in another state to pick up a written prescription, since the local pharmacy would not acknowledge a prescription given remotely.
Gawande questioned why the e-prescribing of controlled substances like opioids, despite being allowed legally, has been adopted in practices representing only 8% of all physicians. Technological capabilities are not the obstacle, as more than 90% of physicians use electronic health records and 81% of pharmacies can receive opioid prescriptions over the internet. Neither is feasibility, as demonstrated in New York, which saw a high rate of physician uptake even before a requirement last year made the use of electronic opioid prescriptions mandatory.
He acknowledged that e-prescribing is far from the only tactic clinicians must use to responsibly treat pain. Current guidelines advise surgeons to prescribe nonopioid alternatives whenever possible, utilize prescription monitoring program databases, clearly instruct patients on how to dispose of unused pills, counsel patients to focus on functioning through pain instead of eliminating it entirely, and prescribe the minimum quantity of painkillers necessary.
The final suggestion is “the trickiest part” for Gawande, as the necessary amount of medication is hard to define and varies by patient. As mentioned earlier, he proposed that an e-prescribing system would help by allowing surgeons to start with a smaller dose and conveniently prescribe more pills if needed.
Gawande, a prolific author, as well as a respected surgeon and professor, concluded the piece with a call to action aimed at those “who cannot sit idly by.”
“We surgeons turn out to be suppliers of the excess prescription opiates fueling addiction and death by overdose,” he wrote. “We have to change that. And we now know how we can.”
Health Equity & Access Weekly Roundup: November 23, 2024
November 23rd 2024Americans are underinsured, even with employer-based health plans; a thorough critique of the lack of representation among Black patients in clinical trials showcases a persistent theme; systemic barriers in cardiology, breast cancer, and patent systems are examined.
Read More
FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy
November 22nd 2024The new drug application (NDA) includes data from a global placebo-controlled, 72-week study as well as findings from the STRIDE registry, an ongoing, observational, real-world study of ataluren in routine care.
Read More